In vitro activities of CB-183,315, vancomycin, and metronidazole against 556 strains of Clostridium difficile, 445 other intestinal anaerobes, and 56 Enterobacteriaceae species
- PMID: 22183166
- PMCID: PMC3294948
- DOI: 10.1128/AAC.05655-11
In vitro activities of CB-183,315, vancomycin, and metronidazole against 556 strains of Clostridium difficile, 445 other intestinal anaerobes, and 56 Enterobacteriaceae species
Abstract
MICs of CB-183,315, a novel lipopeptide antibiotic, vancomycin, and metronidazole were determined for intestinal anaerobes and Enterobacteriaceae. The MIC(90)s for Gram-negative anaerobes were >8,192, 8,192, and 4 μg/ml for CB-183,315, vancomycin, and metronidazole, respectively. Against Enterobacteriaceae, the MIC(90)s were >8,192 μg/ml, 1,024 μg/ml, and 1,024 μg/ml, respectively. The CB-183,315 MIC(90) for Clostridium difficile was 0.5 μg/ml. Its lack of activity against normal fecal organisms makes it a promising new agent for treating C. difficile.
Similar articles
-
Discovery and development of surotomycin for the treatment of Clostridium difficile.J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):195-204. doi: 10.1007/s10295-015-1714-6. Epub 2015 Dec 15. J Ind Microbiol Biotechnol. 2016. PMID: 26670919 Review.
-
Activity of a novel cyclic lipopeptide, CB-183,315, against resistant Clostridium difficile and other Gram-positive aerobic and anaerobic intestinal pathogens.Antimicrob Agents Chemother. 2012 Jun;56(6):3448-52. doi: 10.1128/AAC.06257-11. Epub 2012 Mar 5. Antimicrob Agents Chemother. 2012. PMID: 22391542 Free PMC article.
-
Comparative in vitro activities of LFF571 against Clostridium difficile and 630 other intestinal strains of aerobic and anaerobic bacteria.Antimicrob Agents Chemother. 2012 May;56(5):2493-503. doi: 10.1128/AAC.06305-11. Epub 2012 Jan 30. Antimicrob Agents Chemother. 2012. PMID: 22290948 Free PMC article.
-
In vitro and in vivo activities of the novel Ketolide RBx 14255 against Clostridium difficile.Antimicrob Agents Chemother. 2012 Nov;56(11):5986-9. doi: 10.1128/AAC.00015-12. Epub 2012 Aug 6. Antimicrob Agents Chemother. 2012. PMID: 22869573 Free PMC article.
-
Clostridium difficile bacteremia, Taiwan.Emerg Infect Dis. 2010 Aug;16(8):1204-10. doi: 10.3201/eid1608.100064. Emerg Infect Dis. 2010. PMID: 20678312 Free PMC article. Review.
Cited by
-
Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics.Tetrahedron. 2016 Jun 23;72(25):3609-3624. doi: 10.1016/j.tet.2015.09.069. Epub 2015 Oct 9. Tetrahedron. 2016. PMID: 27429480 Free PMC article.
-
Discovery and development of surotomycin for the treatment of Clostridium difficile.J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):195-204. doi: 10.1007/s10295-015-1714-6. Epub 2015 Dec 15. J Ind Microbiol Biotechnol. 2016. PMID: 26670919 Review.
-
The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies.Antibiotics (Basel). 2019 Jan 24;8(1):8. doi: 10.3390/antibiotics8010008. Antibiotics (Basel). 2019. PMID: 30682820 Free PMC article. Review.
-
Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora.Antimicrob Agents Chemother. 2015 Sep;59(9):5736-46. doi: 10.1128/AAC.01282-15. Epub 2015 Jul 13. Antimicrob Agents Chemother. 2015. PMID: 26169403 Free PMC article.
-
Sub-lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro.J Med Microbiol. 2018 Dec;67(12):1689-1697. doi: 10.1099/jmm.0.000852. Epub 2018 Oct 11. J Med Microbiol. 2018. PMID: 30307842 Free PMC article.
References
-
- Bhalla A, et al. 2003. Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect. Control Hosp. Epidemiol. 24:644–649 - PubMed
-
- Clinical and Laboratory Standards Institute 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteria; 7th ed Approved standard M11-A7. Clinical and Laboratory Standards Institute, Wayne, PA
-
- Collins MD, et al. 1994. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44:812–826 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases